Pharming (PHAR) Cash from Operations (2020 - 2022)
Historic Cash from Operations for Pharming (PHAR) over the last 4 years, with Q2 2023 value amounting to -$32.4 million.
- Pharming's Cash from Operations fell 91055.53% to -$32.4 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$32.4 million, marking a year-over-year decrease of 28856.5%. This contributed to the annual value of $7.1 million for FY2021, which is 9155.65% down from last year.
- Latest data reveals that Pharming reported Cash from Operations of -$32.4 million as of Q2 2023, which was down 91055.53% from $609000.0 recorded in Q4 2022.
- In the past 5 years, Pharming's Cash from Operations registered a high of $17.2 million during Q3 2020, and its lowest value of -$32.4 million during Q2 2023.
- Moreover, its 4-year median value for Cash from Operations was $609000.0 (2022), whereas its average is $1.3 million.
- As far as peak fluctuations go, Pharming's Cash from Operations skyrocketed by 852484.07% in 2022, and later tumbled by 91055.53% in 2023.
- Pharming's Cash from Operations (Quarter) stood at $87263.7 in 2020, then surged by 7991.57% to $7.1 million in 2021, then crashed by 91.38% to $609000.0 in 2022, then crashed by 5421.18% to -$32.4 million in 2023.
- Its Cash from Operations was -$32.4 million in Q2 2023, compared to $609000.0 in Q4 2022 and -$4.6 million in Q3 2022.